SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10546864
Source:
http://linkedlifedata.com/resource/pubmed/id/10546864
Search
Subject
(
51
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0036220
,
umls-concept:C0040223
,
umls-concept:C0162643
,
umls-concept:C0887947
pubmed:issue
15
pubmed:dateCreated
1999-11-24
pubmed:abstractText
To evaluate the impact of highly active antiretroviral therapy (HAART) on Kaposi's sarcoma.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0269-9370
pubmed:author
pubmed-author:BowenII
,
pubmed-author:FifeKK
,
pubmed-author:FoxPP
,
pubmed-author:GazzardBB
,
pubmed-author:GillJJ
,
pubmed-author:NelsonMM
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2105-11
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:10546864-Adult
,
pubmed-meshheading:10546864-Anti-HIV Agents
,
pubmed-meshheading:10546864-Antineoplastic Agents
,
pubmed-meshheading:10546864-Drug Therapy, Combination
,
pubmed-meshheading:10546864-HIV Infections
,
pubmed-meshheading:10546864-HIV Protease Inhibitors
,
pubmed-meshheading:10546864-HIV-1
,
pubmed-meshheading:10546864-Humans
,
pubmed-meshheading:10546864-Middle Aged
,
pubmed-meshheading:10546864-Retrospective Studies
,
pubmed-meshheading:10546864-Reverse Transcriptase Inhibitors
,
pubmed-meshheading:10546864-Sarcoma, Kaposi
,
pubmed-meshheading:10546864-Survival Analysis
,
pubmed-meshheading:10546864-Time Factors
,
pubmed-meshheading:10546864-Treatment Failure
,
pubmed-meshheading:10546864-Viral Load
pubmed:year
1999
pubmed:articleTitle
Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma.
pubmed:affiliation
Department of Oncology, Chelsea and Westminster Hospital, London, UK. m.bower@cxwms.ac.uk
pubmed:publicationType
Journal Article